IP Library Granted Patent US 9,173,966
Granted Patent B2
US 9,173,966 · App. 13/742,190 · Granted Nov 3, 2015

Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

Inventors: Christopher J. Chang (Berkeley, CA); Carolyn R. Bertozzi (Berkeley, CA); Genevieve C. van de Bittner (Berkeley, CA); Elena A. Dubikovskaya (Lausanne, CH)
Assignee: The Regents of the University of California
A61K49/0021C07F5/025A61K31/427
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,173,966
App. No.
13/742,190
Granted
Nov 3, 2015
Kind
B2
Abstract

The present disclosure features a condensation reaction and a luciferin-unmasking reaction that can be carried out under physiological conditions. In general, the condensation reaction involves reacting a bicyclic reactant with an aminothiol derivative, generating a luciferin or luciferin derivative. A luciferin can provide detectable luminescence. A luciferin derivative can be unmasked to provide detectable luminescence in a luciferin-unmasking reaction. The present disclosure provides bicyclic reactants and aminothiol derivatives suitable for use in the condensation reaction. The condensation and luciferin-unmasking reactions find use in a variety of applications, which are also provided.

Claims (13)

1. A compound of formula:

wherein

Q 1 is a heteroatom functional group selected from —O— and —NR Q1 —;

R Q1 is selected from hydrogen, alkyl, and substituted alkyl;

PG IV is an aryl or heteroaryl boronic acid-containing protecting group for the heteroatom functional group;

R 1 is selected from hydrogen, halogen hydroxyl, alkyl, substituted alkyl, alkoxy, amino, and substituted amino; and

PG I is a protecting group for the cyano.

2. A compound having the formula:

3. The compound of claim 1 , wherein PG IV has the formula

wherein:

R 10 and R 11 are hydrogen;

A ring is selected from aryl, substituted aryl, heteroaryl and substituted heteroaryl; and

L 1 is a cleavable linker group.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2013
From: CHANG, CHRISTOPHER J.; BERTOZZI, CAROLYN RUTH; VAN DE BITTNER, GENEVIEVE C.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030523/0097 →
CONFIRMATORY LICENSE Recorded Apr 18, 2013
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030242/0276 →
Continuity (2)
Provisional Application 61587490 · Jan 17, 2012
Related Publication 20130287699A1 · Oct 31, 2013